Showing results (11-20 of 202) with videos related to
Sort By:
Pageof 21
Optics Express|January 22, 2015
Analysis of the THz response of a simple periodic graphite-based structureM P M Colleoni, B VidalPsychopharmacology|May 11, 2000
Precipitated and spontaneous withdrawal in rats tolerant to anandamideB Costa, G Giagnoni, M ColleoniBehavioural Pharmacology|April 26, 2000
SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated ratsB Costa, S Vailati, M ColleoniThe Italian Journal of Gastroenterology|March 1, 1992
Medical treatment of hepatocarcinomaR Buzzoni, E Bajetta, M ColleoniLife Sciences|May 5, 1986
Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonistA Giachetti, R Micheletti, E MontagnaThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
AF-DX 116, a cardioselective muscarinic antagonistR Micheletti, E Montagna, A GiachettiAnnals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello, P Maisonneuve, N Rotmensz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseG Cancello, P Maisonneuve, N Rotmensz, et al.Tumori|April 30, 1993
Fluorouracil plus folinic acid in metastatic adenocarcinoma of unknown primary site suggestive of a gastrointestinal primaryF Nolè, M Colleoni, R Buzzoni, et al.Pageof 21